Zeng Wei-Gen, Liu Meng-Jia, Zhou Zhi-Xiang, Wang Zhen-Jun
1 Department of General Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China 2 Department of Ultrasound, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 3 Department of Colorectal Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Dis Colon Rectum. 2017 Nov;60(11):1175-1183. doi: 10.1097/DCR.0000000000000900.
There is little information about the prognostic value of a microscopically positive distal margin in patients who have rectal cancer.
We aimed to investigate the influence of a distal margin of ≤1 mm on oncologic outcomes after sphincter-preserving resection for rectal cancer.
This is a retrospective cohort study.
The study was conducted at 2 hospitals.
A total of 6574 patients underwent anterior resection for rectal cancer from January 1999 to December 2014; 97 (1.5%) patients with a distal margin of ≤1 mm were included in this study. For comparative analyses, patients were matched with 194 patients with a negative distal margin (>1 mm) according to sex, age, BMI, ASA score, neoadjuvant treatment, tumor location, and stage.
The oncologic outcomes of the 2 groups were compared.
Perineural and lymphovascular invasion rates were significantly higher in patients with a positive distal margin (54.6% vs 28.9%; 67.0% vs 42.8%; both p < 0.001) compared with to patients with negative distal margin. Comparison between microscopically positive and negative distal margin showed worse oncologic outcomes in patients with a microscopically positive distal margin, including 5-year local recurrence rate (24.1% vs 12.0%, p = 0.005); 5-year distant recurrence rate (35.5% vs 20.2%, p = 0.011); 5-year disease-free survival (45.5% vs 69.5%, p < 0.001); and 5-year OS (69.2% vs 79.7%, p = 0.004). Among the 97 patients with a microscopically positive distal margin, the 5-year disease-free survival rate was higher in patients who received adjuvant therapy (52.0% vs 30.7%, p = 0.089).
This is a retrospective study; bias may exist.
A distal margin of 1 mm is associated with worse oncologic results. Our data indicate the importance of achieving a clear distal margin in the surgical treatment of rectal cancer. Adjuvant therapy should be used in these patients to reduce recurrence. See Video Abstract at http://links.lww.com/DCR/A408.
关于直肠癌患者显微镜下切缘阳性的预后价值,相关信息较少。
我们旨在研究直肠癌保肛切除术后切缘≤1毫米对肿瘤学结局的影响。
这是一项回顾性队列研究。
该研究在两家医院进行。
1999年1月至2014年12月,共有6574例患者接受了直肠癌前切除术;本研究纳入了97例(1.5%)切缘≤1毫米的患者。为进行比较分析,根据性别、年龄、体重指数、美国麻醉医师协会(ASA)评分、新辅助治疗、肿瘤位置和分期,将这些患者与194例切缘阴性(>1毫米)的患者进行匹配。
比较两组的肿瘤学结局。
与切缘阴性的患者相比,切缘阳性的患者神经周围和淋巴管侵犯率显著更高(分别为54.6%对28.9%;67.0%对42.8%;p均<0.001)。显微镜下切缘阳性与阴性患者的比较显示,切缘阳性的患者肿瘤学结局更差,包括5年局部复发率(24.1%对12.0%,p = 0.005);5年远处复发率(35.5%对20.2%,p = 0.011);5年无病生存率(45.5%对69.5%,p < 0.001);以及5年总生存率(69.2%对79.7%,p = 0.004)。在97例显微镜下切缘阳性的患者中,接受辅助治疗的患者5年无病生存率更高(52.0%对30.7%,p = 0.089)。
这是一项回顾性研究;可能存在偏倚。
1毫米的切缘与更差的肿瘤学结果相关。我们的数据表明在直肠癌手术治疗中获得清晰切缘的重要性。这些患者应使用辅助治疗以降低复发率。见视频摘要:http://links.lww.com/DCR/A408 。